Epic Systems and several healthcare providers have sued Health Gorilla and other companies, alleging they exploited ...

AI rivals Anthropic and OpenAI are both expanding their large language models into healthcare. Anthropic is blending its enterprise and consumer tools in a single platform, while OpenAI is separating ...

Private equity activity in the global healthcare sector set a new record last year with an estimated $191 billion in deal value, according to new data from Bain & Company. Healthcare remains one of PE ...

Pharmaceutical companies need to spend money in order to make money, and the looming loss of patent exclusivity for numerous products has these companies out in force striking business deals to fill ...

Fullscript has partnered with wearable device company ŌURA to bring its biometric insights into Fullscript’s clinical workflow, the companies announced on Monday during the J.P. Morgan Healthcare ...

Teladoc Health, a virtual care provider, has expanded its 24/7 urgent care service to treat more conditions, the company announced on Monday during the J.P. Morgan Healthcare Conference in San ...

AbbVie is diversifying its oncology pipeline, paying $650 million for a clinical-stage drug that goes after two targets to fight cancer. It’s the latest in a series of industry transactions for assets ...

I am sure that other healthcare journalists, like myself, have received pitches from public relations professionals since OpenAI announced a new tool called ChatGPT Health a few days ago. Many of ...

Cancer care company Color Health is partnering with insurer Evry Health to enhance employer health plans with its cancer care services, according to a Wednesday announcement. Evry Health is a ...

Operating room capacity is a financial backbone for hospitals, but inefficiencies in this department often ripple outward — hurting operating margins, burning out clinicians and reducing patient ...

Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with drugs addressing a promising target offering the potential ...